A. Pinkstaff

Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector.

D. Kayda, K. Sakhuja, M. Kaleko, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice.

D. Kayda, M. Kaleko, S. Connelly, 1999, Human gene therapy.

Development of adenovirus serotype 35 as a gene transfer vector.

M. Kaleko, S. Connelly, S. Ganesh, 2003, Virology.

An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.

Ying Huang, P. Ryan, J. Jakubczak, 2003, Cancer research.

Breeding of retroviruses by DNA shuffling for improved stability and processing yields

W. Stemmer, E. Otto, Willem P.C. Stemmer, 2000, Nature Biotechnology.